Winslow Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$358M |
| 2 |
Boston Scientific
BSX
|
+$312M |
| 3 |
IQVIA
IQV
|
+$310M |
| 4 |
Sherwin-Williams
SHW
|
+$310M |
| 5 |
SLB Ltd
SLB
|
+$248M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$570M |
| 2 |
Union Pacific
UNP
|
+$480M |
| 3 |
Comcast
CMCSA
|
+$371M |
| 4 |
MON
Monsanto Co
MON
|
+$364M |
| 5 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$321M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.47% |
| 2 | Consumer Discretionary | 19.77% |
| 3 | Technology | 15.07% |
| 4 | Communication Services | 14.55% |
| 5 | Financials | 9.39% |
Similar funds
Winslow Capital Management's Q2 2015 Portfolio in Review
As of Q2 2015, Winslow Capital Management held 76 positions worth $30.1B, down 7.2% from $32.5B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Winslow Capital Management withdrew a net $2.86B in Q2 2015, closing 5 positions and reducing 42 holdings. Its most notable exit was Comcast, an estimated $371M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Technology.
Against the trend, Winslow Capital Management opened a new position in Medtronic worth $347M.
- Winslow Capital Management's largest Q2 2015 buy was Medtronic: 4,688,772 shares worth $347M.
- Winslow Capital Management added most to Alibaba in Q2 2015, an estimated $245M increase.
- Winslow Capital Management's biggest Q2 2015 reduction was Amgen, cutting an estimated $570M.
- Winslow Capital Management fully exited Comcast in Q2 2015, selling an estimated $371M.
- Winslow Capital Management's ten largest holdings make up 31% of its $30.1B portfolio in Q2 2015.
- Winslow Capital Management opened 10 new positions and closed 5 in Q2 2015.
- Winslow Capital Management's portfolio value fell 7.2% quarter-over-quarter to $30.1B.
Based on Winslow Capital Management's 13F filing for Q2 2015, filed 13 Aug 2015.